European agency recommends Novo hemophilia drug for approval

COPENHAGEN (Reuters) - Danish insulin maker Novo Nordisk has received a recommendation for marketing approval from a European Medicines Agency (EMA) committee for its hemophilia treatment turoctocog alfa.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/-9_5zthSffg/story01.htm

phlebotomy classes in nyc phlebotomy training in virginia phlebotomy training in fayetteville nc